Trials / Conditions / Borderline Ovarian Serous Tumor
Borderline Ovarian Serous Tumor
3 registered clinical trials studyying Borderline Ovarian Serous Tumor.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Ca NCT02101788 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer NCT00551070 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |